← Open Payments lookup

MICHAEL SANDERS: Open Payments

NPI 1548698954 · SEBRING, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$938 in 44 payments from 13 companies in 2025. Trend: 2023 $263 · 2024 $442 · 2025 $938

Food & beverage: $938
CompanyPaymentsAmount
Otsuka America Pharmaceutical, Inc.7$165
Alkermes, Inc.8$152
Teva Pharmaceuticals USA, Inc.5$118
ABBVIE INC.5$109
Axsome Therapeutics, Inc.3$78
Takeda Pharmaceuticals U.S.A., Inc.3$69
E.R. Squibb & Sons, L.L.C.3$62
Neurocrine BioSciences, Inc.3$60
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)3$57
Vanda Pharmaceuticals Inc.1$22

Products named: REXULTI, ARISTADA, AUSTEDO XR, VRAYLAR, COBENFY, INGREZZA, CAPLYTA, Auvelity.

Industry payments across FL — which companies pay providers there.